{
    "2018-03-31": [
        [
            {
                "time": "",
                "original_text": "【创新药企业IPO系列专题之二】剖析投资机构最关注问题：创新药估值溢价与机构需做如何调整？",
                "features": {
                    "keywords": [
                        "创新药",
                        "IPO",
                        "投资机构",
                        "估值溢价",
                        "调整"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "年报密集披露，哪些机会将显现？",
                "features": {
                    "keywords": [
                        "年报",
                        "披露",
                        "机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}